BioNTech SE (BNTX) Free Cash Flow Growth (1y) (2019 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 60.84% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 88.70% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -15.72% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 66.37% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 3.98% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 137.65% |
| 10 | BioNTech SE | 27.66 Bn | 7.53 Bn | 668.28 Mn | 202.34% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 202.34% |
| Sep 30, 2025 | -47.51% |
| Jun 30, 2025 | -98.34% |
| Mar 31, 2025 | -173.79% |
| Dec 31, 2024 | -142.15% |
| Sep 30, 2024 | -91.50% |
| Jun 30, 2024 | -61.90% |
| Mar 31, 2024 | 58.57% |
| Dec 31, 2023 | 2.06% |
| Sep 30, 2023 | -80.78% |
| Jun 30, 2023 | 13.92% |
| Mar 31, 2023 | -1,470.98% |
| Dec 31, 2022 | 638.01% |
| Sep 30, 2022 | 161.34% |
| Jun 30, 2022 | 2,701.20% |
| Mar 31, 2022 | -86.82% |
| Dec 31, 2021 | 44.39% |
| Sep 30, 2021 | 733.16% |
| Jun 30, 2021 | 790.19% |
| Mar 31, 2021 | 457.62% |
| Dec 31, 2020 | 25.73% |
| Sep 30, 2020 | 310.63% |
| Jun 30, 2020 | -72.11% |
| Mar 31, 2020 | 89.79% |
| Dec 31, 2019 | -433.89% |